A novel C/EBPα-miR-335-5p-PRKAA2 regulatory axis drives hepatic lipid accumulation in MASLD.

No abstract is available for this paper.

• Publication year

  2026

• Venue

  Scientific Reports

• Publication date

  2026-02-16

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1038/s41598-026-38918-5PMID 41699012PMCID PMC13000317
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Rhein alleviates hepatic steatosis in NAFLD mice by activating the AMPK/ACC/SREBP1 pathway to enhance lipid metabolism

  2025cited by this paper
• Codonopsis pilosula polysaccharides attenuate lipid accumulation and inflammatory response in the NAFLD mouse by regulating AMPK/ACC/SREBP1 signaling pathway.

  2025cited by this paper
• Metabolically Healthy Obesity and Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): Navigating the Controversies in Disease Development and Progression

  2025cited by this paper
• Lycium barbarum polysaccharide mitigates high-fat-diet-induced skeletal muscle atrophy by promoting AMPK/PINK1/Parkin-mediated mitophagy.

  2025cited by this paper
• Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD): the interplay of gut microbiome, insulin resistance, and diabetes

  2025cited by this paper
• MASLD development: From molecular pathogenesis toward therapeutic strategies

  2025cited by this paper
• Hepatocyte-specific CCAAT/enhancer binding protein α restricts liver fibrosis progression

  2024cited by this paper
• Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment.

  2024cited by this paper
• Recent Advances in miRNA-Based Therapy for MASLD/MASH and MASH-Associated HCC

  2024cited by this paper
• Role of Circulating microRNAs in Liver Disease and HCC: Focus on miR-122

  2024cited by this paper
• MicroRNAs in metabolic dysfunction‐associated diseases: Pathogenesis and therapeutic opportunities

  2024cited by this paper
• Epidemiology of metabolic dysfunction-associated steatotic liver disease

  2024cited by this paper
• Circulating microRNAs associated with non-alcoholic fatty liver disease.

  2023cited by this paper
• Modulation of MicroRNAs and Exosomal MicroRNAs after Dietary Interventions for Obesity and Insulin Resistance: A Narrative Review

  2023cited by this paper
• MicroRNA-34a Mediates High-Fat-Induced Hepatic Insulin Resistance by Targeting ENO3

  2023cited by this paper
• Identification of key modules and driving genes in nonalcoholic fatty liver disease by weighted gene co-expression network analysis

  2023cited by this paper
• Roles of the peroxisome proliferator-activated receptors (PPARs) in the pathogenesis of nonalcoholic fatty liver disease (NAFLD).

  2023cited by this paper
• C/EBPa confers dependence to fatty acid anabolic pathways and vulnerability to lipid oxidative stress-induced ferroptosis in FLT3-mutant leukemia.

  2023cited by this paper
• Recent evaluation about inflammatory mechanisms in nonalcoholic fatty liver disease

  2023cited by this paper
• C/EBPα promotes triacylglycerol synthesis via regulating PPARG promoter activity in goat mammary epithelial cells.

  2022cited by this paper
• Circ_0064288 acts as an oncogene of hepatocellular carcinoma cells by inhibiting miR-335-5p expression and promoting ROCK1 expression

  2022cited by this paper
• Distinct AMPK-Mediated FAS/HSL Pathway Is Implicated in the Alleviating Effect of Nuciferine on Obesity and Hepatic Steatosis in HFD-Fed Mice

  2022cited by this paper
• New insights into activation and function of the AMPK

  2022cited by this paper
• Key factors and potential drug combinations of nonalcoholic steatohepatitis: Bioinformatic analysis and experimental validation-based study.

  2021cited by this paper
• RETRACTED: MicroRNA-21 Plays Multiple Oncometabolic Roles in the Process of NAFLD-Related Hepatocellular Carcinoma via PI3K/AKT, TGF-β, and STAT3 Signaling

  2021cited by this paper
• MicroRNA Let-7 targets AMPK and impairs hepatic lipid metabolism in offspring of maternal obese pregnancies

  2021cited by this paper
• Hepatocyte miR-34a is a key regulator in the development and progression of non-alcoholic fatty liver disease

  2021cited by this paper
• microRNA profiles of serum exosomes derived from children with nonalcoholic fatty liver

  2021cited by this paper
• The role of AMPKα2 in the HFD-induced nonalcoholic steatohepatitis.

  2020cited by this paper
• miR-335-5p suppresses gastric cancer progression by targeting MAPK10

  2020cited by this paper
• miR-34a regulates lipid metabolism by targeting SIRT1 in non-alcoholic fatty liver disease with iron overload.

  2020cited by this paper
• Transcriptional Regulation in Non-Alcoholic Fatty Liver Disease

  2020cited by this paper
• MicroRNA-29a Disrupts DNMT3b to Ameliorate Diet-Induced Non-Alcoholic Steatohepatitis in Mice

  2019cited by this paper
• Prenatal caffeine exposure increases the susceptibility to non-alcoholic fatty liver disease in female offspring rats via activation of GR-C/EBPα-SIRT1 pathway.

  2019cited by this paper
• The miR-122 inhibition alleviates lipid accumulation and inflammation in NAFLD cell model

  2019cited by this paper
• Lonicera caerulea Extract Attenuates Non-Alcoholic Fatty Liver Disease in Free Fatty Acid-Induced HepG2 Hepatocytes and in High Fat Diet-Fed Mice

  2019cited by this paper
• Structure and Physiological Regulation of AMPK

  2018cited by this paper
• An overview of microRNAs: Biology, functions, therapeutics, and analysis methods

  2018cited by this paper
• AMPK: guardian of metabolism and mitochondrial homeostasis

  2017cited by this paper
• Cell-specific dysregulation of microRNA expression in obese white adipose tissue.

  2014cited by this paper
• C/EBP Homologous Protein (CHOP) Contributes to Suppression of Metabolic Genes during Endoplasmic Reticulum Stress in the Liver*

  2012cited by this paper
• Nonalcoholic steatohepatitis is associated with altered hepatic MicroRNA expression

  2008cited by this paper
• Phosphorylation of CCAAT/Enhancer-binding Protein α Regulates GLUT4 Expression and Glucose Transport in Adipocytes*

  2008cited by this paper
• CCAAT/enhancer binding protein alpha (C/EBPalpha) in adipose tissue regulates genes in lipid and glucose metabolism and a genetic variation in C/EBPalpha is associated with serum levels of triglycerides.

  2008cited by this paper
• C/EBP alpha knock-in hepatocytes exhibit increased albumin secretion and urea production.

  2007cited by this paper
• C/EBPα knock-in hepatocytes exhibit increased albumin secretion and urea production

  2007cited by this paper
• Hepatic CCAAT/enhancer binding protein alpha mediates induction of lipogenesis and regulation of glucose homeostasis in leptin-deficient mice.

  2004cited by this paper
• C/EBPalpha is required for differentiation of white, but not brown, adipose tissue.

  2001cited by this paper
• C/EBPα is required for differentiation of white, but not brown, adipose tissue

  2001cited by this paper

• No citing papers are available for this paper.